Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00137280 · ClinicalTrials.gov registry record · NA

Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)

A NA study of Schizophrenia and Weight Gain, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
1,067
Enrollment target
8
Study locations

NCT00137280 is a NA study of Schizophrenia and Weight Gain that has completed, run by VA Office of Research and Development. The registered enrollment target is 1,067 participants, above the 216-participant average among 315 other Schizophrenia trials with a reported enrollment target (394% higher). The trial reports 8 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00137280, a NA study of Schizophrenia and Weight Gain, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
1,067 participants
Enrollment target
8
Study locations

Study Summary

This project evaluates the implementation and effectiveness of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project provides information to VA clinicians and managers about Veterans with schizophrenia or schizoaffective disorder who are overweight and/or who would like to return to competitive work. The project facilitates reorganization of care practices in order to get veterans needed and desired services around wellness and work. The project creates a platform that other clinical and research interventions can build upon to improve care, and is designed to inform a national strategy for implementing evidence-based care in schizophrenia.

Interventions

  • BEHAVIORAL Collaborative Chronic Illness Care Model

Study Locations (8)

California

  • VA Long Beach Healthcare System, Long Beach, CA - Long Beach
  • VA Greater Los Angeles Healthcare System, West Los Angeles, CA - West Los Angeles

New York

  • Northport VA Medical Center, Northport, NY - Northport
  • James J. Peters VA Medical Center, Bronx, NY - The Bronx

Texas

  • Michael E. DeBakey VA Medical Center, Houston, TX - Houston
  • Central Texas Veterans Health Care System, Temple, TX - Temple

Louisiana

  • Overton Brooks VA Medical Center, Shreveport, LA - Shreveport

Nevada

  • VA Southern Nevada Healthcare System, North Las Vegas, NV - Las Vegas

Trial Details

FieldValue
Enrollment Target 1,067 participants
Start Date 2007-06-13
Est. Completion 2011-05-31
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00137280

The ClinicalTrials.gov registry entry for NCT00137280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,067 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 216-participant average among 315 other Schizophrenia trials with a reported enrollment target (394% higher). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Schizophrenia appearing as the primary indexed condition, and to 1 intervention - of which Collaborative Chronic Illness Care Model is the first listed.

NCT00137280 reports 8 study locations spanning 5 distinct geographic areas - top geographies include California, New York, Texas.

Frequently Asked Questions

What is clinical trial NCT00137280 about?

NCT00137280 is a clinical study titled "Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)". This project evaluates the implementation and effectiveness of a care model to improve treatment for schizophrenia within the context of diverse VA practices and priorities. The project provides information to VA clinicians and managers about Veterans with schizophrenia or schizoaffective disorder w...

What is the current status of trial NCT00137280?

This trial is currently completed. It is a NA study. The enrollment target is 1,067 participants. The study started on 2007-06-13. Estimated completion is 2011-05-31.

What conditions does trial NCT00137280 study?

This clinical trial studies the following conditions: Schizophrenia, Weight Gain, Psychotic Disorder, Chronic Illness.

What interventions are being tested in trial NCT00137280?

The interventions under investigation include: Collaborative Chronic Illness Care Model (BEHAVIORAL).

Who is sponsoring clinical trial NCT00137280?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00137280 being conducted?

This trial has 8 study locations across California, Louisiana, Nevada, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.